Meget almindelige bivirkninger ≥ 10% af patienterne Vægtforøgelse eller vægttab (G3/ 4:
Very common adverse Common adverse reactions reactions ≥ 10% of patients ≥ 1 to < 10% of patients Weight increased or decreased (G3/ 4: